SCIENTIFIC PROGRAM
Day 01 | April 10, 2021
Time Topic Session Chair/ Speakers
08:45 AM – 09:00 AM Inauguration
09:00 AM- 10:45 AM
(25 min talk & 10 min discussion each)		 Session I:
ISBMT/ASTCT/APBMT Joint Session – Advances in Cellular Therapy
Moderator: Ramya		 Session Chair:
Mammen Chandy
Shinichiro Okamoto
Mary E. Flowers
09:00 AM – 09:35 AM Beyond CAR-T cells in ALL Rizwan Romee
09:35 AM – 10:10 AM Cellular therapies to overcome intractable hematological malignancies  – New insight in NK cells Junji Tanaka
10:10 AM – 10:45 AM Development of Indigenous CAR-T Cell Therapy in India Gaurav Narula
10:45 AM – 11:00 AM Break
11:00 AM – 01:00 PM
(20 min talk & 10 min discussion each)		 Session II: Leukemia Session
Moderator: Ramya		 Session Chair:
Shashikant Apte
Sharat Damodar
11:00 AM – 11:30 AM Haplo vs. MUD in AML in 2021 Vikram Mathews
11:30 AM – 12:00 PM TBI vs non TBI conditioning in ALL – (Debate) Vivek Radhakrishnan Vs Dinesh Bhurani
12:00 PM – 12:30 PM Strategies to Prevent Relapse Post Transplant in acute Leukemias Navneet Majhail
12:30 PM – 01:00 PM When to offer transplant in CML – in Indian Setting Ajay Sharma
01:00 – 01:45 PM Educational Symposium by Emcure
01:45 PM – 03:45 PM
(20 min talk & 10 min discussion each)		 Session III: Pediatric Session
Moderator: Anu Korula 		Session Chair:
Mamta Manglani
Revathi Raj
01:45 PM – 02:15 PM Hemoglobinopathies: Are we ready for haploidentical donor transplants? Sunil Bhat
02:15 PM – 02:45 PM Metabolic Disorders HSCT in Indian Context Revathi Raj
02:45 PM – 03:15 PM JMML Allo BMT – When, How and for Whom? Gaurav Kharya
03:15 PM – 03:45 PM Haploidentical transplant for bone marrow failure syndromes Prashant Hiwarkar
03:45 PM – 04:00 PM Break
04:00 PM – 05:30 PM Poster Session
Judges: Reetu Jain, Rajan Kapoor, Smita Kayal,
C N Nair, Krishna Ratnam, Sanjeevan Sharma
05:30 PM – 07:00 PM
(20 min talk & 10 min discussion each)		 Session IV: Lymphoma/ Myeloma
Moderator: Anu Korula		 Session Chair:
Lalit Kumar
Tapan Saikia
05:30 PM – 06:00 PM Optimization of Stem Cell Mobilisation in Lymphomas and Myeloma- strategies to improve yield Pankaj Malhotra
06:00 PM – 06:30 PM Haplo for Hodgkin Lymphoma- Is this the way forward for those requiring allo transplant? Mehdi Hamadani
06:30 PM – 07:00 PM Transplantation in AL Amyloidosis- when and for whom? Shaji Kumar
SCIENTIFIC PROGRAM
Day 02 | April 11, 2021
Time Topic Session Chair/ Speakers
10:00 AM – 12:00 PM
(20 min talk & 10 min discussion each)		 Session V: Infections and Transplant outcomes
Moderator: Punit Jain		 Session Chair:
Santosh Kumar Devdas
Navin Khattry
10:00 AM – 10:30 AM Hepatitis B and C reactivation in transplant setting- incidence, prevention and treatment Harrys Antonio Torres
10:30 AM – 11:00 AM Respiratory Viral infections following HSCT- epidemiology and treatment strategies Tanu Singhal
11:00 AM – 11:30 AM Role of fecal transplant : need in India? Neeraj S
11:30 AM – 12:00 PM Gram Negative Sepsis in HSCT Parikshit Prayag
12:00 PM- 01:30 PM
(8 min talk & 3 min discussion each)		 Session VI:
Oral Presentations
Moderator: Punit Jain		 Session Chair:
Anupam Chakrapani, Ashish Dixit
S Kannan, Pravas Mishra
12:00 PM – 12.11 PM LACE: An effective conditioning regimen for autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma Saikat Datta
12.11 PM – 12:22 PM Single centre experience of etanercept in steroid refractory acute graft versus host disease Akanksha Chichra
12:22 PM – 12:33 PM Autologous stem cell transplant in Non-Hodgkin Lymphoma: AIIMS experience Sudhir Kumar
12:33 PM – 12:44 PM Health-related Quality of Life in transplant eligible multiple myeloma patients with or without early ASCT in the real-world setting Mir M Asrar
12:44 PM – 12:55 PM Comparison of outcomes of Donor Lymphocyte Infusions with or without Lenalidomide in patients with hematological malignancies post allogeneic transplant Sachin Punatar
12:55 PM – 01:06 PM The impact of CD3 and CD34 cell dose on graft rejection and graft versus host disease in children undergoing unrelated peripheral blood stem cell transplantation Satish Kumar Meena
01:06 PM – 01.17 PM Long Term Survivorship after Allogeneic Hematopoietic Cell Transplantation: Real world experience from a transplant centre from North India Niranjan S Khaire
01.17 PM – 01.28 PM Haploidentical transplantation with TCR Alpha/Beta depletion in Pediatric thalassemia after pre transplant immunosuppression Pooja P Mallya
01:30 PM – 02:15 PM Educational Symposium by MSD
Moderator: Anant Gokarn
02:15 PM – 04:15 PM
(20 min talk & 10 min discussion each)		 Session VII: Post transplant Complications including GVHD
Moderator: Anant Gokarn		 Session Chair:
Seema Bhatwadekar
Sarita Jaiswal
02:15 PM – 02:45 PM Cytokine Release Syndrome: How to Diagnose, Evaluate and Manage Uday Kulkarni
02:45 PM – 03:15 PM Reproductive Health post transplant Rishi Dhawan
03:15 PM – 03:45 PM Biomarkers guided treatment of acute GVHD Aby Abraham
03:45 PM – 04:15 PM Management of TA-TMA What is new ? Sachin Punatar
04:15 PM – 06:15 PM ISBMT Members Session – Hall B
(Only for ISBMT Members)		 Session Chair:
Mammen Chandy
Alok Srivastava
04:15 PM – 04:45 PM Current status of ISBMT Registry Data – 2021 Alok Srivastava
04:45 PM – 05:15 PM CDMC Management of ISBMT Registry
a .Activity
b .Minimum Outcome Data (MOD)
– CDMC process for data collection & management
– Online web-based data collection / Redcap system – APBMT		 Kavitha ML
Prasanna PS / Rajagopal A
05:15 PM – 05:35 PM Enhancing data collection for ISBMT
-Training program
-On-site support
-Data Audit		 Kavitha ML
05:35 PM – 05:55 PM Registry based research
– Retrospective / Prospective data collection
– ‘Named’ Registry Study Groups’ (for data already within the registry)		 Alok Srivastava
05:55 PM – 06:15 PM Scientific Committee Issues
– Authorship policies
– ‘Named’ Study Groups (for data beyond what is collected in the registry)		 Sharat Damodar
06:15 PM – 06:30 PM Closing Remarks